Targeting the IL33–NLRP3 axis improves therapy for experimental cerebral malaria

Por Strangward, Patrick, Haley, Michael J., Albornoz, Manuel G., Barrington, Jack, Shaw, Tovah, Dookie, Rebecca, Zeef, Leo, Baker, Syed M., Winter, Emma, Tzeng, Te-Chen, Golenbock, Douglas T., Cruickshank, Sheena M., Allan, Stuart M., Craig, Alister, Liew, Foo Y., Brough, David, Couper, Kevin N.
Publicado no Proc Natl Acad Sci U S A (2018)